ClinicalTrials.gg
RecruitingNCT06429774Updated Sep 4, 2024

Comparative Effectiveness of Intervention in Multi-level Hospitals for Acute Traumatic Brain Injury(Metric-TBI)

An observational study in Traumatic Brain Injury, sponsored by Beijing Tiantan Hospital. Recruiting at 64 sites in China. Open to participants aged 1 Year to 89 Years. Per ClinicalTrials.gov, last updated 2024-09-04.

Sponsored by Beijing Tiantan Hospital · Observational

How we know

From the registry’s dates

  • Started Aug 2024; still recruiting 2 years 3 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
2,000
Ages
1 Year to 89 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 60 studies in Brain Injuries, Traumatic with a site in China — 29 open to participants now, 30 under way, none of them phase 3. Brain Injuries, Traumatic · China.

Planned enrollment
Largest of 34
2,000 · median 110
Started
2024
with 13 others
Observational
34 of 60
19 open now
Primary completion
2026-12
later than 16 of 29 live
Registered
43rd of 60
by date
Lead sponsor
6 of 60
Beijing Tiantan Hospital

Among the 60 studies in Brain Injuries, Traumatic with a site in China, this one has the largest planned enrollment of the 34 observational ones that give a count, is one of 14 that started in 2024, is one of 34 observational ones, reaches primary completion later than 16 of the 29 other live ones, and was the 43rd registered.

Brain Injuries, Traumatic

1,725 studies on the registry are indexed under Brain Injuries, Traumatic; 450 are open to participants now.

Browse Brain Injuries, Traumatic studies →

Open to participants now

29 of the 60 studies in Brain Injuries, Traumatic with a site in China are open now. Recruiting first, the newest first:

23 more — sign in →

All 29 open studies →

A study can be open while its sites in China have not opened yet or have stopped. Only those recruiting at a site in China →

Who these studies take

Of the 287 Brain Injuries, Traumatic studies recruiting now, 126 (44%) set no upper age limit and 119 (41%) stop at 75 or younger; 41 take children under 18; 53 take healthy volunteers.

This study: 1 Year to 89 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 60 studies in Brain Injuries, Traumatic with a site in China, or all of them as a file.
02

Study summary

A prospective, multicenter, observational cohort study is designed to compare the effectiveness of intervention in multi-grade hospitals for acute traumatic brain injury and to optimize clinical outcomes.

Read the detailed description

Traumatic brain injury (TBI) is associated with significant morbidity, mortality, and disability, profoundly impacting public health. This study aims to establish a database for acute craniocerebral trauma within the Beijing-Tianjin-Hebei region, and compiles indicators of hospital treatment capabilities and patient data, including neuroimaging, clinical progression, and rehabilitation prognoses.The study is bifurcated into two segments: the initial phase surveys the current status of acute treatment outcomes for TBI inpatients across hospitals in the Beijing-Tianjin-Hebei region and conducts a comparative effectiveness analysis to identify the clinical interventions to optimize. Subsequent phases build on the former by applying optimized treatment strategies to improve efficacy and establish collaborative optimized treatment protocols.

This is a prospective, multicenter, observational study designed to enroll 2,000 patients under the age of 90 years with traumatic brain injury in the presence of clinical symptoms confirmed by computed tomography or magnetic resonance imaging.The primary outcome is the Extended Glasgow Outcome Score within 12 months. Secondary outcomes include the Generalized Anxiety Disorder-7 (GAD-7), Patient Health Questionnaire-9(PHQ-9), Rivermead post-concussion symptoms questionnaire(RPQ), PTSD Checklist-5 Version(PCL-5),Six-Item Screener (SIS) and 12-Item Short-Form Health Survey version 2(SF-12v2).

The objective of this study is anticipated to the Beijing-Tianjin-Hebei region a 20 percent increase in the number of cases treated by optimized clinical practice guidelines and a 10 percent decrement in mortality and disability rates among TBI patients in the region.

03

Conditions studied

  • Traumatic Brain Injury

Keywords

  • Traumatic Brain Injury
  • Beijing-Tianjin-Hebei region
  • Database
  • Comparative effectiveness of intervention
  • Clinical Treatment Guideline
04

Who can participate

Ages eligible
1 Year to 89 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

TBI patients recruited from neurosurgical departments at 50 medical centers in China have apparent clinical symptoms that are confirmed by computed tomography or magnetic resonance imaging.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patient (1 years to 89 years) presenting with clinical symptoms of traumatic brain injury
  • Traumatic brain injury verified on cranial computed tomography or magnetic resonance imaging
  • Written from patients or their next of kin according to the patient's cognitive status

Exclusion criteria

Exclusion Criteria:

  • patients ≥90 years of age
  • patients who did not accept follow-up visits or were unable to complete follow-up assessments
  • patients with incomplete information
  • patients who did not obtain written
  • patients with concomitant cancer or other serious illnesses
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
2,000 participants (estimated)
Target follow-up
1 Year
Patient registry
Yes
Biospecimen retention
Samples with dna

Groups and cohorts

  • TBI Group

    TBI patients recruited from neurosurgical departments at 50 medical centers in China have apparent clinical symptoms that are confirmed by computed tomography or magnetic resonance imaging. The exclusion criteria are those who fulfill one of the following conditions: 1. patients ≥90 years of age; 2. patients who did not accept follow-up visits or were unable to complete follow-up assessments; 3. patients with incomplete information; 4. patients who did not obtain written informed consent; 5. patients with concomitant cancer or other serious illnesses.

    Other: Neurological function · Other: Mental State, cognitive function, and life quality assessment · Other: Peripheral blood test · Other: Hematoma test

Interventions

  • OtherNeurological function

    Neurological function will be examined using Glasgow Coma Scale (GCS) and Extended Glasgow Outcome Scale (GOSE).The GOSE was created as an advancement from the original GOS. The GOSE score categorizes the prognosis of patients with traumatic brain injury into eight categories.The 8 categories are: Dead, Vegetative State, Lower Severe Disability, Upper Severe Disability, Lower Moderate Disability, Upper Moderate Disability, Lower Good Recovery, and Upper Good Recovery.

  • OtherMental State, cognitive function, and life quality assessment

    Mental State, cognitive function, and life quality will be examined using the Generalized Anxiety Disorder-7 (GAD-7), Patient Health Questionnaire-9(PHQ-9), Rivermead post-concussion symptoms questionnaire(RPQ), PTSD Checklist-5 Version(PCL-5),Six-Item Screener(SIS) and 12-Item Short-Form Health Survey version 2(SF-12v2).

  • OtherPeripheral blood test

    Collect peripheral blood samples from patients.

  • OtherHematoma test

    Collect hematoma fluid, dura mater, and hematoma outer membrane samples from patients.

06

What researchers measure

Primary outcomes

  1. Difference in the Extended Glasgow Outcome Score

    The Extended Glasgow Outcome Scores(GOSE) range from 1 to 8, with higher scores indicating a better outcome. The summary of the scale is below:1.Dead;2. Vegetative State;3. Lower Severe Disability;4. Upper Severe Disability;5. Lower Moderate Disability;6. Upper Moderate Disability;7. Lower Good Recovery;8.Upper Good Recovery.Therefore, a score of 1 represents the worst outcome (death), and a score of 8 represents the best outcome (upper good recovery). The rates of death or severe disability (GOSE scores 1-3) due to traumatic brain injury in the short term (at discharge) and in the long term (3, 6, and 12 months post-discharge) give an indication of the extent to which a patient recovers from different treatments.

    Time frame: From discharge up to 12 months postoperatively

Secondary outcomes

  1. Difference in the Generalized Anxiety Disorder-7 Scale in post-traumatic mental health recovery

    Patients were scored on their subsequent level of mental health at 3, 6, and 12 months after discharge based on the Generalized Anxiety Disorder-7 Scale(GAD-7). The GAD-7 scale consists of seven items, each describing a symptom of Generalized Anxiety Disorder(GAD), and respondents rate how often they've been bothered by each symptom over the past two weeks.The GAD-7 score of 10 suggests moderate anxiety, on a scale ranging from 0 (minimal anxiety) to 21 (severe anxiety), with higher scores indicating worse outcomes.

    Time frame: From discharge up to 12 months postoperatively

  2. Difference in the Patient Health Questionnaire-9 Scale in post-traumatic mental health recovery

    Patients were scored on their subsequent level of mental health at 3, 6, and 12 months after discharge based on the Patient Health Questionnaire-9 Scale(PHQ-9). The PHQ-9 scale consists of nine items, each describing a symptom of depression, and respondents rate how often they've been bothered by each symptom over the past two weeks. The PHQ-9 scores between 10-14 suggest moderate depression, on a scale ranging from 0 (minimal depression) to 27 (severe depression), with higher scores indicating worse outcomes.

    Time frame: From discharge up to 12 months postoperatively

  3. Difference in the Rivermead Post-Concussive Symptoms Questionnaire Scale in post-traumatic mental health recovery

    Patients were scored on their subsequent level of mental health at 3, 6, and 12 months after discharge based on the Rivermead Post-Concussive Symptoms Questionnaire(RPQ). The RPQ score ranges from 0 (no symptoms) to 64 (severe symptoms). Higher scores on the RPQ indicate a greater severity of post-concussive symptoms and a worse outcome. This information helps healthcare providers assess the impact of the concussion on the patient's daily life and track their recovery progress.

    Time frame: From discharge up to 12 months postoperatively

  4. Difference in the Post-Traumatic Stress Disorder Checklist-5 Scale in post-traumatic mental health recovery

    Patients were scored on their subsequent level of mental health at 3, 6, and 12 months after discharge based on the Post-Traumatic Stress Disorder Checklist-5 (PCL-5). Each of the 20 items on the PCL-5 is rated on a scale from 0 ("Not at all") to 4 ("Extremely"). The PCL-5 score ranges from 0 to 80, with higher scores indicating worse Post-traumatic stress disorder(PTSD) symptoms.

    Time frame: From discharge up to 12 months postoperatively

  5. Difference in life quality assessment

    Patients were scored on their subsequent level of quality of life at 3, 6, and 12 months after discharge based on different scores on the 12-item Short-Form Health Survey 2 (SF-12v2). The SF-12v2 provides two summary scores: the Physical Component Summary (PCS) score and the Mental Component Summary (MCS) score. For both the PCS and MCS scores range from 0(the lowest level of health) to 100(the highest level of health). Higher scores on the PCS and MCS indicate better physical and mental health, respectively.

    Time frame: From discharge up to 12 months postoperatively

  6. Difference in cognitive function

    Patients were scored on their subsequent level of cognitive function at 3, 6, and 12 months after discharge based on different scores on the Six-Item Screener (SIS). The SIS is a brief cognitive assessment tool used primarily to screen for cognitive impairment. The SIS assesses orientation and recall, two critical components often affected in cognitive disorders such as dementia.It ranges from 0 to 6, with higher scores mean a better outcome in terms of cognitive function.

    Time frame: From discharge up to 12 months postoperatively

  7. Rate of complications and adverse events

    Rates of complications and adverse events during hospitalization and 12 months after discharge.

    Time frame: From discharge up to 12 months postoperatively

07

Study locations

4 of 64 sites recruiting
  • Beijing Fengtai You'anmen Hospital
    Beijing, Beijing 100000, China
    Not yet recruiting
  • Beijing Huairou Hospital
    Beijing, Beijing 100000, China
    Not yet recruiting
  • Beijing Luhe Hospital,Capital Medical University
    Beijing, Beijing 100000, China
    Not yet recruiting
  • Beijing Red Cross Emergency Medical Center
    Beijing, Beijing 100000, China
    Not yet recruiting
  • Beijing Tsinghua Changgung Hospital
    Beijing, Beijing 100000, China
    Recruiting
  • Peking University People's Hospital
    Beijing, Beijing 100000, China
    Not yet recruiting
  • Beijing Chaoyang Hospital, Capital Medical University
    Beijing, Beijing 100020, China
    Not yet recruiting
  • Beijing Chaoyang Integrative Medicine Rescue And First Aid Hospital
    Beijing, Beijing 100020, China
    Not yet recruiting
  • Beijing Daxing District People's Hospital
    Beijing, Beijing 100020, China
    Not yet recruiting
  • Peking University International Hospital
    Beijing, Beijing 100020, China
    Not yet recruiting
  • Beijing Tiantan Hospital, Capital Medical University
    Beijing, Beijing 100070, China
    Recruiting
    • Weiming Liu, MD · Contactliuweimingnsok@sina.com · 13701182770
    • Weiming Liu, MD · Principal investigator
    • Guoyi Gao, MD · Sub investigator
    • Dongling Sun, MD · Sub investigator
  • Beijing Changping Hospital
    Beijing, Beijing 102200, China
    Not yet recruiting
  • Beijing Mentougou District Hospital
    Beijing, Beijing 102300, China
    Not yet recruiting
  • Liangxiang Hospital
    Beijing, Beijing 102400, China
    Not yet recruiting
  • The First Hospital of Fangshan District, Bejing
    Beijing, Beijing 102400, China
    Not yet recruiting
  • Dongfang Hospital of Beijing University of Chinese Medicine
    Beijing, Beijing 102401, China
    Not yet recruiting
    • Gesheng Wang, M.D. · Contact+86 13581759316
  • Affiliated Hospital Of Hebei University
    Baoding, Hebei 071000, China
    Not yet recruiting
  • The No.2 Hospital of Baoding
    Baoding, Hebei 071000, China
    Not yet recruiting
  • Anguo Hospital
    Baoding, Hebei 071200, China
    Not yet recruiting
  • Rongcheng People's Hospital
    Baoding, Hebei 071799, China
    Not yet recruiting
  • Xiongxian Hospital
    Baoding, Hebei 071800, China
    Not yet recruiting
  • Baoding Seventh Hospital
    Baoding, Hebei 072150, China
    Not yet recruiting
  • Gaobeidian Hospital
    Baoding, Hebei 074099, China
    Recruiting
  • Yixian Hospital
    Baoding, Hebei 074299, China
    Not yet recruiting
  • Suning Hospital
    Cangzhou, Hebei 062350, China
    Not yet recruiting
  • Pingquan Hospital
    Chengde, Hebei 067599, China
    Not yet recruiting
  • Luanping Hospital
    Chengde, Hebei 068250, China
    Not yet recruiting
  • Hangang Hospital
    Handan, Hebei 056000, China
    Not yet recruiting
  • Weixian Chinese Traditional Medicine Hospital
    Handan, Hebei 056800, China
    Not yet recruiting
  • The No.1 Hospital Of Yongnian District Handan City
    Handan, Hebei 057150, China
    Not yet recruiting
  • Hebei Petro China Central Hospital
    Langfang, Hebei 065000, China
    Not yet recruiting
  • Langfang People's Hospital
    Langfang, Hebei 065000, China
    Recruiting
  • Edelburg Hospital
    Langfang, Hebei 065099, China
    Not yet recruiting
  • Sanhe Hospital
    Langfang, Hebei 065201, China
    Not yet recruiting
  • Yanjiao Fuhe No.1 Hospital
    Langfang, Hebei 065201, China
    Not yet recruiting
  • Dachang Hui Autonomous County People's Hospital
    Langfang, Hebei 065300, China
    Not yet recruiting
  • Xianghe Hospital
    Langfang, Hebei 065400, China
    Not yet recruiting
  • Fourth people's Hospital of Langfang
    Langfang, Hebei 065701, China
    Not yet recruiting
  • Dacheng Hospital
    Langfang, Hebei 065900, China
    Not yet recruiting
  • First Hospital of Qinhuangdao
    Qinhuangdao, Hebei 066199, China
    Not yet recruiting
  • Shanhaiguan People's Hospital
    Qinhuangdao, Hebei 066299, China
    Not yet recruiting
  • Qinhuangdao Funing District Hospital of Traditional Chinese Medicine
    Qinhuangdao, Hebei 066399, China
    Not yet recruiting
  • Lulong Hospital
    Qinhuangdao, Hebei 066499, China
    Not yet recruiting
  • Peking University Third Hospital Qinhuangdao Hospital
    Qinhuangdao, Hebei 100083, China
    Not yet recruiting
  • The Second Hospital of Hebei Medical University
    Shijia Zhuang, Hebei 050061, China
    Not yet recruiting
  • The Fourth Hospital of Hebei Medical University
    Shijiazhuang, Hebei 050000, China
    Not yet recruiting
  • The Third Hospital Of Shijiazhuang
    Shijiazhuang, Hebei 050000, China
    Not yet recruiting
  • Jingxing Hospital
    Shijiazhuang, Hebei 050300, China
    Not yet recruiting
  • Xinle Chinese Traditional Medicine Hospital
    Shijiazhuang, Hebei 050700, China
    Not yet recruiting
  • Tangshan Fengrun People's Hospital
    Tangshan, Hebei 063000, China
    Not yet recruiting
  • Tangshan Workers' Hospital
    Tangshan, Hebei 063000, China
    Not yet recruiting
  • Xingtai Central Hospital
    Xingtai, Hebei 054000, China
    Not yet recruiting
  • Xingtai People's Hospital
    Xingtai, Hebei 054001, China
    Not yet recruiting
  • Xingtai Xindu District People's Hospital
    Xingtai, Hebei 054001, China
    Not yet recruiting
  • Xingtai Nanhe District People's Hospital
    Xingtai, Hebei 054499, China
    Not yet recruiting
  • Pingxiang People's Hospital
    Xingtai, Hebei 054599, China
    Not yet recruiting
  • Wei County People's Hospital
    Xingtai, Hebei 054799, China
    Not yet recruiting
  • Qinghe Central Hospital
    Xingtai, Hebei 054802, China
    Not yet recruiting
  • Xingtai Ninth Hospital
    Xingtai, Hebei 055250, China
    Not yet recruiting
  • Tianjin First Central Hospital
    Tianjin, Tianjin 300000, China
    Not yet recruiting
  • Tianjin Hospital
    Tianjin, Tianjin 300000, China
    Not yet recruiting
  • Tianjin Fourth Central Hospital
    Tianjin, Tianjin 300074, China
    Not yet recruiting
  • Tianjin Xiqing Hospital
    Tianjin, Tianjin 300381, China
    Not yet recruiting
  • Wuqing People's Hospital
    Tianjin, Tianjin 301799, China
    Not yet recruiting
08

References and documents

Publications

  • Capizzi A, Woo J, Verduzco-Gutierrez M. Traumatic Brain Injury: An Overview of Epidemiology, Pathophysiology, and Medical Management. Med Clin North Am. 2020 Mar;104(2):213-238. doi: 10.1016/j.mcna.2019.11.001. PubMed 32035565 ↗
  • Galgano M, Toshkezi G, Qiu X, Russell T, Chin L, Zhao LR. Traumatic Brain Injury: Current Treatment Strategies and Future Endeavors. Cell Transplant. 2017 Jul;26(7):1118-1130. doi: 10.1177/0963689717714102. PubMed 28933211 ↗
  • Jiang JY, Gao GY, Feng JF, Mao Q, Chen LG, Yang XF, Liu JF, Wang YH, Qiu BH, Huang XJ. Traumatic brain injury in China. Lancet Neurol. 2019 Mar;18(3):286-295. doi: 10.1016/S1474-4422(18)30469-1. Epub 2019 Feb 12. PubMed 30784557 ↗
  • Stocchetti N, Carbonara M, Citerio G, Ercole A, Skrifvars MB, Smielewski P, Zoerle T, Menon DK. Severe traumatic brain injury: targeted management in the intensive care unit. Lancet Neurol. 2017 Jun;16(6):452-464. doi: 10.1016/S1474-4422(17)30118-7. PubMed 28504109 ↗
  • Steyerberg EW, Wiegers E, Sewalt C, Buki A, Citerio G, De Keyser V, Ercole A, Kunzmann K, Lanyon L, Lecky F, Lingsma H, Manley G, Nelson D, Peul W, Stocchetti N, von Steinbuchel N, Vande Vyvere T, Verheyden J, Wilson L, Maas AIR, Menon DK; CENTER-TBI Participants and Investigators. Case-mix, care pathways, and outcomes in patients with traumatic brain injury in CENTER-TBI: a European prospective, multicentre, longitudinal, cohort study. Lancet Neurol. 2019 Oct;18(10):923-934. doi: 10.1016/S1474-4422(19)30232-7. PubMed 31526754 ↗
  • Silverberg ND, Duhaime AC, Iaccarino MA. Mild Traumatic Brain Injury in 2019-2020. JAMA. 2020 Jan 14;323(2):177-178. doi: 10.1001/jama.2019.18134. No abstract available. PubMed 31816030 ↗
  • Sun D, Jiang B, Ru X, Sun H, Fu J, Wu S, Wang L, Wang L, Zhang M, Liu B, Wang W; for the NESS-China investigators. Prevalence and Altered Causes of Traumatic Brain Injury in China: A Nationwide Survey in 2013. Neuroepidemiology. 2020;54(2):106-113. doi: 10.1159/000501911. Epub 2019 Dec 18. PubMed 31851999 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Aug 2024 (actual). Primary completion is estimated for Dec 2026, 28 months after the start.

Of 231 non-industry observational studies under Brain Injuries, Traumatic, half reached primary completion within 50 months of starting (the median), counting those still running; a quarter within 23 and three quarters within 95. This study's planned 28 months is below that.

Counting every sponsor, half of 253 studies reached it within 49 months; a quarter within 23 and three quarters within 95.

How these figures are worked out, and which studies are left out of them.

Registered
May 16, 2024
First posted
May 28, 2024
StartActual
Aug 1, 2024
Primary completionEst.
Dec 31, 2026
CompletionEst.
Dec 31, 2026
Last update
Sep 4, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 4, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06429774
Responsible party
Weiming Liu (Professor, Beijing Tiantan Hospital) — Principal investigator
First posted
May 28, 2024
Start date
Aug 1, 2024
Primary completion
Dec 31, 2026 (estimated)
Completion
Dec 31, 2026 (estimated)
Last update
Sep 4, 2024

Study contacts

Weiming Liu, M.D.
Contact
liuweimingnsok@sina.com
13701182770
Yu Shi, M.D.
Contact
shiyu199709@163.com
13611533819
Weiming Liu, M.D.
principal investigator · Beijing Tiantan Hospital

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion